Global Pain Management Market Size - Forecasts to 2026

The research conducted by GME analyzed that the Global Pain Management Market will expand at a CAGR value of 4.75% to reach USD 84.50 billion by 2026 from USD 62.40 billion by 2021. The well-established market of painkiller drugs as the first line of treatment is a major contributor to the global pain management market's growth. The other factors supporting the growth of the pain management market are introduction of technologically advanced products, growing cases of cancer, and the high prevalence of diabetes.

Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on “Global Pain Management Market” - Forecast to 2026” https://www.globalmarketestimates.com/market-report/pain-management-market-3365

By Mode of Pain Management (Drugs [Opoids, Non-Narcotic Analgesics], Devices [Neurostimulation Devices, Analgesic Infusion Pumps]), By Application (Neuropathic Pain, Facial Pain and Migraine, Cancer Pain, Musculoskeletal Pain, Other Applications), By Region (North America, Europe, Asia Pacific, MEA, and CSA); End-User Landscape, Vendor Landscape, and Company Market Share Analysis and Competitor Analysis

Key Market Insights:
• As of 2020, device-based pain management therapies have been more popular, as people have become more reliant on them for longer periods and have gained a better understanding of their negative effects.
• The neurostimulation devices are analyzed to hold the biggest revenue share in 2020 as these neurostimulators are extremely important in the treatment of chronic pain, depression, epilepsy, Parkinson's disease, and movement disorders.
• The cancer pain application will be the fastest-growing segment with the highest CAGR value from 2021 to 2026.
• The growing government frameworks along with the rising healthcare infrastructure are some of the factors increasing the pain management market size in the US during the forecast period.
• Abbott Laboratories, Baxter International Inc., Galt Pharmaceuticals, Becton, Dickinson and Company, Boston Scientific Corporation, Fresenius SE & Co. KGaA, GlaxoSmithKline PLC, Johnson & Johnson, Medtronic PLC, Novartis International AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd, Eli Lilly and Company, Endo Health Solutions, Inc (Endo International PLC), Merck & Co, Inc., Mylan N.V, Purdue Pharma LP, B Braun Melsungen AG, Nevro Corp., Colfax Corporation, Omron Healthcare Inc., Smiths Medical, Stryker Corporation, and Stimwave LLC, among others are some of the key players in the market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/pain-management-market-3365

Based on Mode of Pain Management Outlook (Revenue, USD Billion, 2021 - 2026)
• Drugs
• Opioids
• Non-Narcotic Analgesics
• Devices
• Neurostimulation Devices
• Analgesic Infusion Pumps

Based on Application Outlook (Revenue, USD Billion, 2021 - 2026)
• Neuropathic Pain
• Facial Pain and Migraine
• Cancer Pain
• Musculoskeletal Pain
• Other Applications

Regional Outlook (Revenue, USD Billion, 2021 – 2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Chile
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• South Africa
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: [email protected]
Phone Number: +16026667238
Website: Global Market Estimates
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php